Kaiser study of 3.3 million members finds single case of NSF

May 7, 2008 Kaiser study of 3.3 million members finds single case of NSF James Brice -------------------------------------------------------------------------------- A comprehensive evaluation of Magnevist use among the 3.3 million members of Kaiser Permanente in Northern California has found a lower risk for developing nephrogenic systemic fibrosis than reported in previous studies in renal disease patients who received gadolinium-based MR contrast media. Lead author Thomas A. Hope, Ph.D., noted that four earlier reports on the prevalence of NSF found that 2.3% to 4% of dialysis-dependent patients who underwent a gadolinium-enhanced MRI study developed NSF. The reported rate for patients with decreased renal function is about 1.5%

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC